• Events 

    Friday, December 4, 2015 | 8:30 AM - 6:00 PM

    Managing Disease-Related Lean Body Mass Loss through Clinical and Nutrition Interventions

    Speakers: Melissa J. Benton (University of Colorado at Colorado Springs), David Evans (The Ohio State University), Gordon Jensen (The Pennsylvania State University), Robert Martindale (Oregon Health & Science University Healthcare), Peter A. McCullough (Dallas Baylor Heart and Vascular Hospital), Gerard Mullin (Johns Hopkins Medicine), Dennis H. Sullivan (University of Arkansas), Paul Wischmeyer (University of Colorado School of Medicine)

    Lean Body Mass Loss Clinical and Nutrition Interventions

    Monday, December 7, 2015 | 1:30 PM - 4:30 PM

    Genome Integrity Discussion Group

    Speakers: Jean Gautier (Columbia University Medical Center), Olga A. Guryanova (Weill Cornell Medical College), Jaspreet S. Khurana (Princeton University), Hannah Klein (NYU Langone Medical Center), Neal Lue (Weill-Cornell Medical College), Dirk Remus (Memorial Sloan Kettering Cancer Center)

    The Genome Integrity Discussion Group provides a forum for interactions between basic and clinical research groups working on chromosome biology and function, and at the interface between chromosome integrity and onset and progression of malignancy.

    Tuesday, December 8, 2015 | 8:30 AM - 5:00 PM

    GLP-1 Treatment for Diabetes and Beyond

    Speakers: David D'Alessio (Duke University), Richard DiMarchi (Indiana University), Jean-Philippe Fortin (Pfizer Global), Keld Fosgerau (Zealand Pharma), Matthew Hayes (Perelman School of Medicine, University of Pennsylvania), George Holz (State University of New York), Dong Seok Kim (National Institute on Aging / Peptron Inc), Lotte Bjerre Knudsen (Novo Nordisk), Patrick Sexton (Monash University), Konrad Talbot (Cedars-Sinai Medical Center), Beat Jucker (GlaxoSmithKline)

    GLP-1 receptor agonists have improved treatment options in type 2 diabetes, although realizing their promise in other areas remains challenging. This symposium highlights preclinical and clinical breakthroughs and opportunities for drug development.

    Wednesday, December 9, 2015 | 7:00 PM - 8:30 PM

    The Moral Animal: Virtue, Vice & Human Nature

    Featuring Heather Berlin (Icahn School of Medicine at Mt. Sinai Hospital), Christian Miller (Wake Forest University), Michael Shermer (Chapman University), and Walter Sinnott-Armstrong (Duke University)
    Moderator: Steve Paulson (Wisconsin Public Radio)

    Is a basic model of human nature necessary to navigate the good life? Professor of philosophy Christian Miller and neuroscientist Heather Berlin join forces with science writer Michael Shermer to take a closer look at our moral ecology and its influence on our underlying assumptions about human nature.

    Monday, February 1, 2016 | 1:30 PM - 4:30 PM

    Genome Integrity Discussion Group

    Speakers: Alberto Ciccia (Columbia University Medical Center), Maria Jasin (Memorial Sloan Kettering Cancer Center), Richard Pomerantz (Temple University), Patrick Sung (Yale University)

    The Genome Integrity Discussion Group provides a forum for interactions between basic and clinical research groups working on chromosome biology and function, and at the interface between chromosome integrity and onset and progression of malignancy.

  • Past Events

    Thursday, November 19, 2015 | 8:30 AM - 5:30 PM

    Little Beans, Big Opportunities: Realizing the Potential of Pulses to Meet Today's Global Health Challenges

    Speakers: Seth Adu-Afarwuah (University of Ghana), Vincent Amanor-Boadu (Kansas State University), Richard Black (PepsiCo), Laurette Dubé (McGill University), Allan Hruska (United Nations Food and Agricultural Organization), PK Joshi (International Food Policy Research Institute), Mark J Manary (Washington University School of Medicine in St Louis), Danielle Nierenberg (Food Tank), Sonny Ramaswamy (USDA National Institute of Food and Agriculture), John L. Sievenpiper (University of Toronto), Joanne Slavin (University of Minnesota)

    This inaugural conference will look at the role of pulses in healthy and sustainable diets, examine how pulses can make critical contributions to public health, and explore opportunities for enhancing these benefits broadly through food system innovations.

    Monday, November 16, 2015 | 6:30 PM - 8:30 PM

    Current Evidence on Non-caloric Sweeteners and their Health Implications

    Speakers: Kiyah Duffey (Virginia Tech), Gary D. Foster (Weight Watchers International, Inc), John Glendinning (Barnard College), Rick Mattes (Purdue University)

    This evening event will unpack current scientific research from multiple disciplines, regarding the effect of non-caloric sweeteners currently approved by the Food and Drug Administration for use in foods and beverages in the United States, on weight management and health.

    October 28 - 29, 2015

    Pre-Approval Access: Can Compassion, Business, and Medicine Coexist?

    This 2-day colloquium will explore challenges surrounding pre-approval access to investigational medicines in a series of debates featuring prominent representatives of governments, pharmaceutical companies, patient groups, NGOs, and foundations.

    Tuesday, October 27, 2015 | 8:00 AM - 5:00 PM

    Phenotypic and Biomarker-Based Drug Discovery

    Speakers: Andras J. Bauer (Boehringer Ingelheim USA), Myles Fennell (Memorial Sloan-Kettering Cancer Center), Michael R. Jackson (Sanford Burnham Prebys Medical Discovery Institute), Jonathan A. Lee (Eli Lilly), Martin Main (AstraZeneca), Friedrich Metzger (F. Hoffmann-La Roche Ltd), Bruce A. Posner (University of Texas, Southwestern Medical Center), Yao Shen (Columbia University), Aravind Subramanian (Broad Institute), Giulio Superti-Furga (Austrian Academy of Sciences), Susanne Swalley (Novartis Institutes for Biomedical Research), Jitao David Zhang (F. Hoffmann-La Roche Ltd.)

    This symposium aims to deepen our understanding of phenotypic drug discovery and to foster the exchange of ideas between industry-based and academic research scientists.

  • Publications 


    The Year in Evolutionary Biology

    Edited by Timothy A. Mousseau (University of South Carolina) and Charles W. Fox (University of Kentucky)

    The seventh installment of this Annals series presents scholarly reviews on current topics in evolutionary biology.

    Volume 1360


    The Year in Cognitive Neuroscience

    Edited by Michael B. Miller (University of California, Santa Barbara) and Alan Kingstone (University of British Columbia)

    The eighth installment of this Annals series presents review articles on recent developments in cognitive neuroscience research.

    Volume 1359


    From Tumor Suppressors to Oncogenic Dynamics: The 2015 Dr. Paul Janssen Award Symposium

    Featured Speaker: Bert Vogelstein (Johns Hopkins School of Medicine; Howard Hughes Medical Institute)

    This eBriefing features the work of Bert Vogelstein, recipient of the 2015 Dr. Paul Janssen Award for Biomedical Research, and covers topics at the forefront of precision medicine.


    Pharmaceutical Science to Improve the Human Condition: Winners and Finalists of the Prix Galien USA Awards 2014

    Edited by Annals of the New York Academy of Sciences editorial staff

    This Annals volume presents scientific achievements by winners and finalists of the 2014 Prix Galien USA, honoring excellence in pharmaceutical science.

    Volume 1358